Pharmacotherapy and Community Psychiatric Practice
Abstract
Thirty-two outpatients at a community mental health center were treated in a double-blind study using thioridazine and a placebo. The target symptom of anxiety was observed and measured prior to treatment and at weekly interviews for four weeks. It was found that treatment with thioridazine, compared to placebo, produced reduction of anxiety and increased motivation to remain in treatment and follow through with treatment recommendations. The authors stress the implications of their findings for community psychiatric practice.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
